Related Experiment Videos

Misuse of Pirated Drugs: Why China? What Is Next?

Hui-Wen Sun¹, Yi-Long Wu¹

¹Guangdong General Hospital and Guangdong Academy of Medical Science, Guangzhou, China.

Journal of Global Oncology

|July 19, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV).

Translational lung cancer research·2023

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients.

Cancer treatment and research communications·2023

A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.

Future oncology (London, England)·2023

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study.

Cell reports. Medicine·2023

Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies.

Targeted oncology·2023

See all related articles